Affording IMBRUVICA® (ibrutinib)Affording IMBRUVICA® (ibrutinib)

IMBRUVICA® (ibrutinib)

Change Condition

Coverage and Cost

When you have support, such as help understanding your insurance coverage and potential ways to pay for IMBRUVICA®, you may feel more confident during treatment. The IMBRUVICA® By Your Side patient support program is here to help answer some of your questions about the financial aspects of taking IMBRUVICA®.

Learn more about your insurance coverage and potential financial support options. 

Call the IMBRUVICA® By Your Side patient support program

1-888-YourSide (1-888-968-7743)

Monday-Friday, 8:00am-8:00pm ET


If you have commercial insurance, you could get IMBRUVICA® for as little as


per prescription*

*Eligible patients may pay as little as $0 per prescription of IMBRUVICA®. Rules and maximum limits apply. Patients currently using the IMBRUVICA® Copay Card are not eligible for retroactive billing or reimbursement of previous copays. The IMBRUVICA® Copay Card is available to patients with commercial prescription coverage for IMBRUVICA® who meet eligibility criteria. The IMBRUVICA® Copay Card cannot be used by patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs, including Medicare Part D, Medicare Advantage Plan, Medicaid, Medigap, VA, DOD, and TRICARE, or where prohibited by law or the patient’s health insurance provider. The IMBRUVICA® Copay program may be updated or discontinued at any time without notice.

Enroll for the IMBRUVICA® Copay Card

Understanding Insurance

Most people have healthcare and prescription drug insurance coverage through a private organization or the federal or state government.

Commercial (or private) insurance

Commercial insurance is coverage you have through your employer, or that you’ve purchased from a private insurance company or the health insurance marketplace. 

If you have commercial insurance, you may be eligible to pay as little as $0 per prescription of IMBRUVICA® with the IMBRUVICA® Copay Card.

Government insurance

You may have insurance coverage through the federal government or the state where you live. Common plans include Medicare, Medicare Part D, Medicaid, VA, and TRICARE.

If you have a government insurance plan, potential financial support for IMBRUVICA® may be available through an independent foundation. 

Other Resources

Johnson & Johnson Patient Assistance Foundation, Inc.

The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is an independent, nonprofit organization. JJPAF gives eligible patients free prescription medicines donated by Johnson & Johnson companies. To see if you might qualify for assistance, please contact a JJPAF program specialist at 800-652-6227 (Monday – Friday, 8:00 AM to 8:00 PM ET) or visit the foundation website at


The IMBRUVICA® By Your Side patient support program is with you along the way.

Get Started Today

Pharmacyclics, an AbbVie Company, may collect your personal data through your online and offline interactions with us, including your contact, demographic, geolocation, and health-related data. We may also collect your online usage data automatically through cookies and similar technologies. We use this data for several purposes, such as to provide you with and improve our programs, services, and products, customize your experiences, and for research and analytics. We retain your personal data for as long as necessary to fulfill these purposes or to comply with our record retention obligations. We do not sell your personal data but may use and disclose your personal data with marketing and advertising partners to deliver you ads based on your interests inferred from your activity across other unaffiliated sites and services (“online targeted advertising”) and for website analytics. To opt out of the use or disclosure of your personal data for online targeted advertising or for website analytics, go to Your Privacy Choices on our website. For more information on the personal data categories we collect, the purposes for their collection, our disclosures to third parties, your data subject rights, and our data retention criteria, visit our Privacy Notice.

Through my submission of the program enrollment form, I consent to the collection, use, and disclosure of my personal health data, as described in the Privacy Notice above and in AbbVie’s Privacy Notice in the How We May Disclose Personal Data section. My consent is required to process sensitive personal data under certain privacy laws, and I have the right to withdraw my consent by visiting Your Privacy Choices on AbbVie’s website.

IMBRUVICA® (ibrutinib) is covered by U.S. Patents, which are listed in FDA's Orange Book (available at